S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RA Capital Management/Q3 2021

RA Capital Management

Period: Q3 2021 Β· Filed: 2021-11-15
View on SEC EDGAR β†—
AUM
$7.22B
Total portfolio value
Positions
95
Reported securities
Top Holding
ASND
16.3% $1.18B
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2021-11-15) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
ASNDASCENDIS PHARMA A/S$1.18B16.32%$159.39$274.50+72.2%
16.3%
NVAXNOVAVAX INC$434.9M6.03%$207.31$9.74-95.3%
6.0%
CLYMELIEM THERAPEUTICS INC$236.4M3.28%$17.98$12.90-28.3%
3.3%
IVVDADAGIO THERAPEUTICS INC$225.6M3.13%$42.24$0.89-97.9%
3.1%
FMTXFORMA THERAPEUTICS HLDGS INC$209.0M2.90%β€”β€”
2.9%
CTKBCYTEK BIOSCIENCES INC$205.7M2.85%$21.41$4.59-78.6%
2.9%
AVIRATEA PHARMACEUTICALS INC$190.3M2.64%$35.06$4.98-85.8%
2.6%
JANXJANUX THERAPEUTICS INC$187.6M2.60%$21.63$15.54-28.2%
2.6%
VORXXXXVOR BIOPHARMA INC$174.4M2.42%β€”β€”
2.4%
AVTEAEROVATE THERAPEUTICS INC$173.4M2.40%β€”β€”
2.4%
ICVXICOSAVAX INC$171.0M2.37%β€”β€”
2.4%
DICEDICE THERAPEUTICS INC$170.6M2.36%β€”β€”
2.4%
CNTBXXXXCONNECT BIOPHARMA HLDGS LTD$169.4M2.35%β€”β€”
2.4%
NKTXNKARTA INC$155.9M2.16%$27.81$3.22-88.4%
2.2%
ABOSACUMEN PHARMACEUTICALS INC$145.2M2.01%$14.86$2.74-81.6%
2.0%
TGTXTG THERAPEUTICS INC$136.4M1.89%$33.28$53.31+60.2%
1.9%
TVTXTRAVERE THERAPEUTICS INC$136.2M1.89%$24.25$56.92+134.7%
1.9%
TYRATYRA BIOSCIENCES INC$127.3M1.76%$17.59$30.62+74.1%
1.8%
MGNXMACROGENICS INC$124.5M1.72%$20.94$4.71-77.5%
1.7%
ITOSITEOS THERAPEUTICS INC$119.3M1.65%β€”β€”
1.6%
DAWNDAY ONE BIOPHARMACEUTICALS I$117.8M1.63%β€”β€”
1.6%
IMGNIMMUNOGEN INC$104.4M1.45%β€”β€”
1.4%
PHATPHATHOM PHARMACEUTICALS INC$100.0M1.39%$32.10$11.20-65.1%
1.4%
PCVXVAXCYTE INC$98.9M1.37%$25.37$58.39+130.2%
1.4%
ETNB89BIO INC$97.3M1.35%β€”β€”
1.4%
TILINSTIL BIO INC$87.1M1.21%$357.50$7.73-97.8%
1.2%
CLDXCELLDEX THERAPEUTICS INC NEW$86.4M1.20%$53.99$38.37-28.9%
1.2%
KNTEKINNATE BIOPHARMA INC$82.7M1.15%β€”β€”
1.1%
HOWLWEREWOLF THERAPEUTICS INC$73.7M1.02%$17.16$0.34-98.0%
1.0%
TNYATENAYA THERAPEUTICS INC$73.3M1.02%$20.65$0.79-96.2%
1.0%

Quarter-on-Quarter Activity

Q3 2021 vs. Q2 2021

New Positions (8)

TickerIssuerNotionalSince Filing
CLYMELIEM THERAPEUTICS INC$236.4M-28.3%
IVVDADAGIO THERAPEUTICS INC$225.6M-97.9%
CTKBCYTEK BIOSCIENCES INC$205.7M-78.6%
ICVXICOSAVAX INC$171.0M
DICEDICE THERAPEUTICS INC$170.6M
ABOSACUMEN PHARMACEUTICALS INC$145.2M-81.6%
TYRATYRA BIOSCIENCES INC$127.3M+74.1%
CLDXCELLDEX THERAPEUTICS INC NEW$86.4M-28.9%

Exited Positions (8)

TickerIssuerNotional
AXSMAXSOME THERAPEUTICS INC$111.7M
CRISCURIS INC$57.6M
CERECEREVEL THERAPEUTICS HLDNG INC$56.4M
TRILLIUM THERAPEUTICS INC$51.3M
ARDXARDELYX INC$46.1M
LEGNLEGEND BIOTECH CORP$40.1M
INZYINOZYME PHARMA INC$34.1M
BCTGBCTG ACQUISITION CORP$14.2M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
CNTACENTESSA PHARMACEUTICALS PLC$31.3M+179.4%
EYPTEYEPOINT PHARMACEUTICALS INC$11.8M+76.8%
TGTXTG THERAPEUTICS INC$6.7M+22.6%+60.2%
ASNDASCENDIS PHARMA A/S$282.2M+8.5%+72.2%
CYTTCYTEIR THERAPEUTICS INC$-10.7M+3.2%
GHRSGH RESEARCH PLC$1.8M+1.2%
AVIRATEA PHARMACEUTICALS INC$75.0M+1.1%-85.8%
PCVXVAXCYTE INC$11.8M+0.8%+130.2%

Trimmed (6)

TickerIssuerNotionalShares Ξ”Since Filing
VRDNVIRIDIAN THERAPEUTICS INC$-5.7M-99.7%
CCXICHEMOCENTRYX INC$-43.1M-93.8%
ZGNXZOGENIX INC$-40.7M-36.9%
NVAXNOVAVAX INC$-108.6M-18.1%-95.3%
ORTXORCHARD THERAPEUTICS PLC$-28.7M-10.4%
NAUTNAUTILUS BIOTECHNOLOGY INC$-10.0M-1.4%
← Back to Hedge Funds